Toggle light / dark theme

Sia Performs “Unstoppable” To Close the 2025 Breakthrough Prize Ceremony

Multi-platinum recording artist Sia closed the Breakthrough Prize ceremony with an inspiring rendition of “Unstoppable” as all prize laureates returned to the stage to a standing ovation.
__
The eleventh Breakthrough Prize awards celebrated outstanding scientific achievements, honoring scientists driving remarkable discoveries in gene editing, human diseases, the search for the fundamental laws of the Universe and pure mathematics. Held at the Barker Barker Hangar in Santa Monica, CA, presentations were given by Christina Aguilera, Drew Barrymore, MrBeast, Lily Collins, Vin Diesel, Jodie Foster, Gal Gadot, Salma Hayek Pinault, Ke Huy Quan, Gayle King, Edward Norton, Gwyneth Paltrow, Seth Rogen, Lauren Sanchez, Jeremy Strong, will.i.am, and more. With live performances by Katy Perry and Sia. Continued at https://breakthroughprize.org/News/92.

Full show: • 2025 Breakthrough Prize Ceremony: Full Show.

https://breakthroughprize.org

Optimizing RNA design with AI and an Ising machine: Encoding matters

RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene therapies to genome editing and synthetic biology. However, designing RNA molecules that reliably fold into a desired secondary structure remains a major challenge. Even for relatively short sequences, the number of possible nucleotide combinations grows exponentially, making it difficult to identify optimal candidates. As a result, conventional computational methods often require extensive candidate evaluations, creating a significant bottleneck when experimental validation is both time-consuming and costly.

To address this challenge, researchers from Keio University, led by Project Lecturer Shuta Kikuchi of the Graduate School of Science and Technology and Professor Shu Tanaka of the Department of Applied Physics and Physico-Informatics, developed a novel RNA inverse folding framework based on factorization machine with quadratic optimization annealing (FMQA). This machine learning– and Ising machine–driven black-box optimization approach is designed to identify high-quality RNA sequence candidates with relatively few evaluations.

“We investigated a new application of FMQA in biomolecular design, where its potential remains relatively unexplored. Since RNA, DNA and protein sequences are inherently categorical in nature, it is unclear how converting them into binary representations affects optimization performance. In this study, we examined RNA inverse folding and the influence of different encoding and assignment choices within FMQA,” says Dr. Kikuchi. The findings are published in Scientific Reports.

How a Revolutionary Cancer Treatment Could Reset the Immune Systems of Patients With Autoimmune Diseases

But there are other possible CAR T risks for autoimmune patients. In February, FDA officials published a paper endorsing CAR T’s potential in autoimmunity but warning of “unpredictable long-term toxicity.” CAR T treatment for cancer, the authors noted, has been linked to diverse long-term issues such as Parkinson’s disease. There have also been cases in which the bioengineered cells themselves turned malignant, causing new, T cell-based cancers.

Causing a secondary cancer may be an acceptable risk when treating a life-threatening cancer, but probably not for autoimmunity, says Matt Lunning, medical director for gene and cellular therapy at Nebraska Medicine, in Omaha. How to balance the risk between the impacts of an autoimmune disease, which can range widely in severity, and the difficult-to-quantify risk of future side effects or cancers remains a major open question.

Researchers are already working on second-and third-generation versions of CAR T that they expect to be safer for both cancer and autoimmunity. For example, James Howard, a neuromuscular neurologist at the University of North Carolina at Chapel Hill, is testing a technology from a company called Cartesian Therapeutics that encodes the CAR using molecules of mRNA, the short-lived genetic messenger used in Covid-19 vaccines, instead of long-lasting DNA. The CAR T cells should wipe out B cells for only as long as the mRNA persists, then lose their B cell-targeting abilities. With no chance for genetically modified T cells to hang around long-term, there should be no cancer risk.

DiGem- Digital Twin

🧬 What if every human had their own Digital Twin?

Not in 100 years.

Not in science fiction.

But within our lifetime.

For the past months, I’ve been building DiGem — a project focused on creating a Human Digital Twin: a digital representation of a person that combines health data, AI, lifestyle habits, and gamification into one system.

Imagine:

⚡ Your body displayed as a dashboard 🧠 AI acting as your personal health coach 📈 Real-time monitoring of your health and performance 🎮 Improving yourself through levels, XP, and achievements 🧬 A digital twin that evolves together with you.

Scientists Recreate Life’s Building Blocks | Artificial Cell Performs Life-Like Functions | WION

Scientists have unveiled a synthetic cell capable of performing several life-like functions, marking a major milestone in modern biology. The breakthrough does not mean researchers have created life from scratch, but it does bring science closer to understanding how living systems emerge from simple chemical components. The artificial cell, known as \.

Scientists Turned Human Cells into Tiny Biological Computers

The researchers also built in a warning signal. When the cell received a confusing instruction—the biological equivalent of two commands arriving at once—it produced a separate alert instead of continuing as if nothing had happened.

To show how the system might one day be used in medicine, the team programmed cells to secrete IL-15, an immune protein that can help activate cancer-fighting immune cells.

The experiments relied on engineered circuits delivered into cells under controlled lab conditions. The authors note several challenges ahead, including avoiding unwanted RNA interactions, limiting leaky genetic switches, and finding reliable ways to insert larger circuits into cell genomes.

Nanozymes map nanoparticle routes inside live cells without genetic engineering

Nanoparticles are widely used in medicine to deliver drugs, genes or imaging agents to specific parts of the body. Once a nanoparticle reaches a cell, however, many things can happen—it can reach its target, be degraded, interact with proteins that help transport it, or interact with proteins that hinder its transport.

A longstanding problem in designing nanomedicines has been understanding what happens to nanoparticles at the cellular level, but scientists have faced many challenges. For example, optical microscopy imaging techniques provide only a generalized view of nanomedicine localization.

On the other hand, proteomics approaches require cell lysis, which disrupts the natural distribution of proteins around the nanoparticle, making it difficult to understand how nanoparticles are transported within the cell. Another method—proximity labeling—enables in situ investigation of intracellular protein-protein interactions, but it relies on genetically engineered enzyme fusion, which limits its applicability across diverse systems.

Brain dynamics of the « wave of death » highlighted for the first time

In 2023, scientists at the Paris Brain Institute investigated one of the most fascinating and unsettling transitions in neuroscience: what happens to the cortex when the brain is deprived of oxygen.

In a rat model of systemic anoxia, researchers found that the dying brain does not simply “shut off” all at once. Instead, cortical activity follows a structured sequence: brief high-frequency activity, slowing oscillations, electrical silence, and then a massive wave of anoxic depolarization — often called the “wave of death.”

This wave appeared to begin deep in the neocortex, especially around layer 5 pyramidal neurons, before spreading upward toward the cortical surface and downward toward the white matter. These neurons are large, metabolically demanding projection cells, which may make them especially vulnerable when oxygen and ATP collapse.

But the most important part of the study is that this wave did not always represent an absolute point of no return. When oxygenation was restored within a critical window, researchers observed a “wave of resuscitation,” followed by partial recovery of synaptic activity.

That does not mean death has been “reversed” in a simple or sensational sense. But it does suggest something scientifically powerful: the boundary between life and death in the brain may be more dynamic, layered, and measurable than we often imagine.

This is where the implications become fascinating.

If the “wave of death” is an organized biophysical event, future neurocritical care may one day be able to detect the brain’s approach toward irreversible injury in real time. Instead of relying only on broad markers like heartbeat, oxygen saturation, or flat EEG, clinicians may eventually use more detailed brain-state monitoring to identify whether the cortex is entering a reversible, borderline, or irreversible phase.

/* */